A detailed history of Prudential Financial Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Prudential Financial Inc holds 265,990 shares of ALKS stock, worth $7.54 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
265,990
Previous 307,548 13.51%
Holding current value
$7.54 Million
Previous $7.41 Million 0.46%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$23.01 - $28.55 $956,249 - $1.19 Million
-41,558 Reduced 13.51%
265,990 $7.45 Million
Q2 2024

Aug 13, 2024

SELL
$23.21 - $27.24 $1.61 Million - $1.89 Million
-69,344 Reduced 18.4%
307,548 $7.41 Million
Q1 2024

May 14, 2024

BUY
$26.4 - $32.56 $975,691 - $1.2 Million
36,958 Added 10.87%
376,892 $10.2 Million
Q4 2023

Feb 13, 2024

BUY
$23.37 - $28.68 $1.44 Million - $1.77 Million
61,600 Added 22.13%
339,934 $9.43 Million
Q3 2023

Nov 13, 2023

BUY
$27.17 - $31.97 $4.87 Million - $5.73 Million
179,201 Added 180.77%
278,334 $7.8 Million
Q2 2023

Aug 11, 2023

BUY
$28.34 - $33.63 $997,738 - $1.18 Million
35,206 Added 55.07%
99,133 $3.1 Million
Q1 2023

May 12, 2023

BUY
$25.31 - $29.02 $1.26 Million - $1.44 Million
49,702 Added 349.4%
63,927 $1.8 Million
Q4 2022

Feb 14, 2023

SELL
$21.94 - $26.24 $1.77 Million - $2.11 Million
-80,586 Reduced 85.0%
14,225 $0
Q3 2022

Nov 04, 2022

SELL
$22.0 - $31.87 $765,336 - $1.11 Million
-34,788 Reduced 26.84%
94,811 $2.13 Million
Q2 2022

Aug 15, 2022

BUY
$26.4 - $30.54 $718,027 - $830,626
27,198 Added 26.56%
129,599 $3.86 Million
Q1 2022

May 13, 2022

SELL
$23.07 - $27.99 $2.59 Million - $3.14 Million
-112,189 Reduced 52.28%
102,401 $2.69 Million
Q4 2021

Feb 14, 2022

SELL
$21.47 - $32.08 $2.96 Million - $4.42 Million
-137,635 Reduced 39.08%
214,590 $4.99 Million
Q3 2021

Nov 15, 2021

BUY
$23.37 - $32.13 $3.34 Million - $4.59 Million
142,900 Added 68.27%
352,225 $10.9 Million
Q2 2021

Aug 16, 2021

BUY
$18.78 - $25.15 $3.65 Million - $4.89 Million
194,530 Added 1314.84%
209,325 $5.13 Million
Q1 2019

May 15, 2019

BUY
$28.4 - $36.49 $218,680 - $280,973
7,700 Added 108.53%
14,795 $0
Q4 2018

Feb 07, 2019

BUY
$27.94 - $44.61 $193,205 - $308,478
6,915 Added 3841.67%
7,095 $209,000
Q3 2018

Sep 01, 2021

SELL
$38.6 - $46.12 $266,919 - $318,919
-6,915 Reduced 97.46%
180 $8,000
Q3 2018

Nov 07, 2018

BUY
$38.6 - $46.12 $270,972 - $323,762
7,020 Added 9360.0%
7,095 $0
Q2 2018

Sep 01, 2021

SELL
$40.56 - $51.36 $309,067 - $391,363
-7,620 Reduced 99.03%
75 $3,000
Q2 2018

Aug 13, 2018

SELL
$40.56 - $51.36 $4,056 - $5,136
-100 Reduced 1.28%
7,695 $0
Q1 2018

May 04, 2018

SELL
$53.61 - $67.26 $69,693 - $87,438
-1,300 Reduced 14.29%
7,795 $0
Q3 2017

Nov 02, 2017

BUY
$49.16 - $54.45 $447,110 - $495,222
9,095
9,095 $462,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.66B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.